Roche warned that President Trump's executive order on drug pricing threatens its planned $50 billion investment in the United States

The committee awarded a grant to Genentech, a Roche subsidiary, to open a 420-worker, drug-manufacturing plant in the fast-growing part of southwestern Wake County. Roche pledged to create these jobs between 2028 and 2032 at an average yearly salary of at least $119,800.

Roche envisions its Indianapolis site as a “major hub” for the manufacturing of its continuous glucose monitoring systems. The news comes on the heels of an announced $700 million investment in North Carolina.

Roche Group said on Monday that it plans to invest more than $700 million in a new drug manufacturing facility in North Carolina, the latest drugmaker to expand its presence in the United States amid President Donald Trump's tariff policies.

So far in his second term, President Donald Trump has been trying to coerce international corporations to bolster their spending in the United States, including through his controversial tariffs. | President Donald Trump's recent executive order on drug prices threatens Roche's ability to fund the tens of billions of U.

Roche said Monday it plans to invest up to $550 million and add hundreds of jobs over the next five years at its Indianapolis-based diagnostics unit.

The commitment is part of Roche’s recently announced $50 billion investment in the U.S., but a company spokesperson said that could change if certain yet-unspecified policies are implemented that could “harm our industry’s ability to operate and innovate in America.

AS Monaco and Roche Bobois, a French brand specializing in high-end furnishings and decoration with an international reputation, are delighted to announce the extension of their partnership for a

The National Health Insurance Authority has signed an expanded Memorandum of Understanding with a leading multinational healthcare company, Roche, to enhance access to affordable cancer care and treatment.